Biorem Inc Stock Revenue
| BRM Stock | CAD 3.00 0.02 0.67% |
BioRem Inc fundamentals help investors to digest information that contributes to BioRem's financial success or failures. It also enables traders to predict the movement of BioRem Stock. The fundamental analysis module provides a way to measure BioRem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioRem stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 25.2 M | 18.5 M |
BioRem | Revenue |
BioRem Inc Company Revenue Analysis
BioRem's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current BioRem Revenue | 25.17 M |
Most of BioRem's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioRem Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
BioRem Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for BioRem is extremely important. It helps to project a fair market value of BioRem Stock properly, considering its historical fundamentals such as Revenue. Since BioRem's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BioRem's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BioRem's interrelated accounts and indicators.
Click cells to compare fundamentals
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
BioRem Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, BioRem Inc reported 25.17 M of revenue. This is 99.28% lower than that of the Machinery sector and 89.24% lower than that of the Industrials industry. The revenue for all Canada stocks is 99.73% higher than that of the company.
BioRem Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioRem's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioRem could also be used in its relative valuation, which is a method of valuing BioRem by comparing valuation metrics of similar companies.BioRem is currently under evaluation in revenue category among its peers.
BioRem Current Valuation Drivers
We derive many important indicators used in calculating different scores of BioRem from analyzing BioRem's financial statements. These drivers represent accounts that assess BioRem's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BioRem's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 15.5M | 20.9M | 32.3M | 13.6M | 12.3M | 9.6M | |
| Enterprise Value | 9.1M | 12.8M | 33.5M | 14.6M | 13.1M | 9.0M |
BioRem Fundamentals
| Return On Equity | 0.6 | ||||
| Return On Asset | 0.15 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 43.54 M | ||||
| Shares Outstanding | 15.8 M | ||||
| Shares Owned By Insiders | 1.90 % | ||||
| Shares Owned By Institutions | 0.44 % | ||||
| Number Of Shares Shorted | 2.67 K | ||||
| Price To Earning | 3.01 X | ||||
| Price To Book | 4.73 X | ||||
| Price To Sales | 1.53 X | ||||
| Revenue | 25.17 M | ||||
| Gross Profit | 6.24 M | ||||
| EBITDA | 3.47 M | ||||
| Net Income | 2.18 M | ||||
| Cash And Equivalents | 5.75 M | ||||
| Cash Per Share | 0.16 X | ||||
| Total Debt | 4.19 M | ||||
| Debt To Equity | 1.05 % | ||||
| Current Ratio | 2.24 X | ||||
| Book Value Per Share | 0.43 X | ||||
| Cash Flow From Operations | 490.03 K | ||||
| Short Ratio | 0.21 X | ||||
| Earnings Per Share | 0.29 X | ||||
| Beta | 0.85 | ||||
| Market Capitalization | 46.45 M | ||||
| Total Asset | 24.08 M | ||||
| Retained Earnings | (1.92 M) | ||||
| Working Capital | 6.71 M | ||||
| Net Asset | 24.08 M |
About BioRem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioRem Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioRem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioRem Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioRem Stock Analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.